2004

Effect of Expression Levels and Activating Mutations on the Signalling by the Epidermal Growth Factor Receptor
Zandi R, Johansen LD, Pedersen MW, Poulsen HS

09.30-09.45

UPARAP/endo180 directs lysosomal delivery and degradation of collagen IV.
Lars Kjøller, Lars H. Engelholm, Maria Høyer-Hansen, Keld Danø, Thomas H. Bugge and Niels Behrendt.

09.45-10.00

A role for the testis specific heat shock protein HSPA2 in cancer cell growt hand survival.
Rohde M, Daugaard Jensen M, Helin K1, Jäättelä M.

10.00-10.15

Tumorigenesis-associated sensitization to tumor necrosis factor-mediated cell death depends on cathepsin B
Nicole Fehrenbacher, Mads Gyrd-Hansen, Birgit Poulsen, Ute Felbor, Tuula Kallunki, Marianne Boes, Ekkehard Weber, Marcel Leist and Marja Jäättelä

10.15-10.30

Bcl-2 inhibits autophagy via its localization to the ER.
Maria Høyer-Hansen, Ida Stenfeldt Mathiasen, David Andrews, Brian Leber, Lone Bastholm, Folmer Elling, Michelangelo Campanella and Marja Jäättelä.

10.30.11.00

POSTERS & kaffe

SESSION II: Clinical investigations
Chairmen: Marianne Nordsmark og Cai Grau

11.00-11.15

Expression of MMP-9 in human colon cancer and their liver metastases.
Martin Illemann, Nigel Bird, Ali Majid, Maxwell Sehested, Leif R Lund, Keld Danø and Boye Schnack Nielsen.

11.15-11.30

Inhibitors of apoptosis (IAP) as targets for spontaneous T-cell responses in cancer patients: potential universal antigens in therapeutic vaccinations against cancer.
Andersen MH, Reker, S, Kvistgaard, P, Ralfkiaer, E, Østergaard Pedersen, L, E.Svane, IM, Becker, JC, thor Straten, P.

11.30-11.45

Prediction of clinical normal tissue radiosensitivity from single nucleotide polymorphisms in candidate genes.
Andreassen CN, Alsner J, Rosenstein BS, Overgaard M and Overgaard J

11.45-12.00

MULTI-BIOMARKER PANEL FOR DIAGNOSIS OF EARLY STAGE OVARIAN CANCER
Caspersen M, Fernvik E, Iversen P, Fung E

12.00-12.45

Gårdejer Ingemann Petersen og Hustrus Fond,
Dansk Selskab for Cancerforsknings hæderspris

12.45-13.30

Frokost

13.30-14.00

POSTERS

SESSION III: Experimental therapy and animal models
Chairmen: Leif Lund og Mogens Spang-Thomsen

14.00-14.15

Antisense LNA targeting of P-glycoprotein mRNA in multidrug resistant cell lines.
Jens Eriksen, Sakari Kauppinen, Carsten Alsbo, Peter Stein

14.15-14.30

Significant antitumor effect after systemic administration of a urokinase activation-dependent modified anthrax toxin.
Birgitte Rønø, John Rømer, Thomas Bugge, Shihui Liu, Stephen H. Leppla, and Paul E. G. Kristjansen

14.30-14.45

The role of C/EBP mutations in acute myeloid leukemia: A transgenic model.
Schuster MB, Porse BT, Theilgaard-Mönch K, Nerlov C

14.45-15.00

uPARAP is a mesenchymal collagen internalization receptor that facilitates tumor progression.
Engelholm LH, Curino A, Schnack-Nielsen B, List K, Lars Kjøller, Larsen JK, Danø K, Behrendt N and Bugge TH

15.00-15.30

POSTERS og kaffe

15.30-16.30

The Danish Cancer Society lecture:
Novel mechanisms of cancer suppression and therapy: RhoB as a target of farnesyl tranferase inhibitors (FTls)
by George C. Prendergast, Thomas Jefferson University, USA

16.30-16.45

Pause med øl/vand

16.45-16.50

Uddeling af pris for bedste foredrag
Bedømmelseskomité: Per Guldberg og Hans Skovgaard Poulsen

Lars Engelholm (tv) overrækkes pris for bedste foredrag af Hans Skovgaard Poulsen

Årets modtager af pris for bedste foredrag - Lars Engelholm fra Finsenlaboratoriet.

16.50-16.55

Uddeling af pris for bedste posterpræsentation
Bedømmelseskomité: Nils Brünner og Per Thor Straten

Per Thor Straten overrækker andenprisen for bedste poster til deling mellem Nanna Junker og Tina Klitmøller Sørensen Agander.

Førsteprisen for bedste poster overrækkes af Per Thor Straten (th) til Thomas Kirkegaard Sørensen.

16.55-17.15

Tildeling af æresmedlemsskab

Overlæge, Professor emeritus Jørgen Rygaard modtager årets æresmedlemskab af DSCF af selskabets sekretær Eva Løbner Lund.

18.30

Festmiddag